DE60029327D1 - Nukleinsaüre- und aminosaürensequenzen von infectious salmon anaemia virus, und deren verwendung als impfstoffe - Google Patents

Nukleinsaüre- und aminosaürensequenzen von infectious salmon anaemia virus, und deren verwendung als impfstoffe

Info

Publication number
DE60029327D1
DE60029327D1 DE60029327T DE60029327T DE60029327D1 DE 60029327 D1 DE60029327 D1 DE 60029327D1 DE 60029327 T DE60029327 T DE 60029327T DE 60029327 T DE60029327 T DE 60029327T DE 60029327 D1 DE60029327 D1 DE 60029327D1
Authority
DE
Germany
Prior art keywords
acid sequences
nucleic acid
amino
vaccines
anaemia virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60029327T
Other languages
English (en)
Other versions
DE60029327T2 (de
Inventor
Steven Griffiths
Jane Ritchie
Joel Heppell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27255591&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60029327(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9918588.6A external-priority patent/GB9918588D0/en
Priority claimed from GB0005848A external-priority patent/GB0005848D0/en
Priority claimed from GB0006674A external-priority patent/GB0006674D0/en
Application filed by Novartis AG filed Critical Novartis AG
Application granted granted Critical
Publication of DE60029327D1 publication Critical patent/DE60029327D1/de
Publication of DE60029327T2 publication Critical patent/DE60029327T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Color Image Communication Systems (AREA)
  • Saccharide Compounds (AREA)
  • Paper (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DE60029327T 1999-08-07 2000-08-07 Nukleinsaüre- und aminosaürensequenzen von infectious salmon anaemia virus, und deren verwendung als impfstoffe Expired - Lifetime DE60029327T2 (de)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GBGB9918588.6A GB9918588D0 (en) 1999-08-07 1999-08-07 Sequence
GB9918588 1999-08-07
GB0005848A GB0005848D0 (en) 2000-03-11 2000-03-11 Sequence
GB0005848 2000-03-11
GB0006674 2000-03-21
GB0006674A GB0006674D0 (en) 2000-03-21 2000-03-21 Sequence
PCT/GB2000/002976 WO2001010469A2 (en) 1999-08-07 2000-08-07 Nucleic acid and amino acid sequences of infectious salmon anaemia virus and their use as vaccines

Publications (2)

Publication Number Publication Date
DE60029327D1 true DE60029327D1 (de) 2006-08-24
DE60029327T2 DE60029327T2 (de) 2007-07-05

Family

ID=27255591

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60029327T Expired - Lifetime DE60029327T2 (de) 1999-08-07 2000-08-07 Nukleinsaüre- und aminosaürensequenzen von infectious salmon anaemia virus, und deren verwendung als impfstoffe

Country Status (12)

Country Link
US (7) US6919083B1 (de)
EP (2) EP1637614A3 (de)
AT (1) ATE332712T1 (de)
AU (1) AU6304100A (de)
CA (1) CA2378437C (de)
CY (1) CY1106175T1 (de)
DE (1) DE60029327T2 (de)
DK (2) DK1200132T4 (de)
ES (1) ES2267553T3 (de)
NO (1) NO328740B1 (de)
PT (1) PT1200132E (de)
WO (1) WO2001010469A2 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1637614A3 (de) 1999-08-07 2006-11-29 Novartis AG Nukleinsäure und Antikörper zum Nachweis von infektiösem Lachsanämievirus
DE60017229D1 (de) * 1999-10-18 2005-02-10 Akzo Nobel Nv DNA kodierend für das Strukturalprotein-1 vom infektiösen Lachs Anämie Virus und ihre Verwendungen
AU4078401A (en) * 2000-03-08 2001-09-17 University Court Of The University Of Aberdeen, The Viral antigen and vaccine against isav (infectious salmon anaemia virus)
WO2002026784A2 (en) * 2000-09-28 2002-04-04 Akzo Nobel N.V. Matrix proteins m1 and m2 of infections salmon anaemia virus
GB0216414D0 (en) 2002-07-15 2002-08-21 Novartis Ag Organic compounds
NZ578541A (en) 2006-12-22 2012-04-27 Soluciones Biotecnologicas Innovacion Ltda Dna vaccines for fish
WO2011041790A1 (en) 2009-10-02 2011-04-07 The Trustees Of Columbia University In The City Of New York Piscine reovirus diagnostic compositions
WO2013151662A2 (en) * 2012-03-09 2013-10-10 Samuel Bogoch Therapies, vaccines, and predictive methods for infectious salmon anemia virus

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO311648B1 (no) 1999-05-31 2001-12-27 Genomar Asa DNA-sekvenser som kan benyttes til vaksine, forebyggende helsearbeid på fisk og akvatiske organismer og ellers innenbiomedisin, vektor, vaksine mot ILA-virus samt diagnostisk sett
EP1637614A3 (de) 1999-08-07 2006-11-29 Novartis AG Nukleinsäure und Antikörper zum Nachweis von infektiösem Lachsanämievirus
DE60017229D1 (de) 1999-10-18 2005-02-10 Akzo Nobel Nv DNA kodierend für das Strukturalprotein-1 vom infektiösen Lachs Anämie Virus und ihre Verwendungen
WO2001049712A2 (en) 2000-01-07 2001-07-12 Akzo Nobel N.V. Vaccine against isav (infectious salmon anaemia virus)
AU4078401A (en) 2000-03-08 2001-09-17 University Court Of The University Of Aberdeen, The Viral antigen and vaccine against isav (infectious salmon anaemia virus)
WO2002026784A2 (en) 2000-09-28 2002-04-04 Akzo Nobel N.V. Matrix proteins m1 and m2 of infections salmon anaemia virus

Also Published As

Publication number Publication date
EP1200132B1 (de) 2006-07-12
ATE332712T1 (de) 2006-08-15
EP1200132B2 (de) 2010-02-17
US20120071630A1 (en) 2012-03-22
DE60029327T2 (de) 2007-07-05
US7128917B2 (en) 2006-10-31
US20050164176A1 (en) 2005-07-28
US6919083B1 (en) 2005-07-19
US20100136038A1 (en) 2010-06-03
WO2001010469A3 (en) 2001-09-07
CA2378437A1 (en) 2001-02-15
US20070041988A1 (en) 2007-02-22
NO20020573D0 (no) 2002-02-05
WO2001010469A2 (en) 2001-02-15
EP1200132A2 (de) 2002-05-02
AU6304100A (en) 2001-03-05
DK177298B1 (en) 2012-10-15
EP1637614A3 (de) 2006-11-29
US7998484B2 (en) 2011-08-16
US7199108B2 (en) 2007-04-03
ES2267553T3 (es) 2007-03-16
EP1637614A2 (de) 2006-03-22
US20050261227A1 (en) 2005-11-24
US20040146860A1 (en) 2004-07-29
PT1200132E (pt) 2006-11-30
US7201910B2 (en) 2007-04-10
CA2378437C (en) 2014-01-21
NO20020573L (no) 2002-04-05
NO328740B1 (no) 2010-05-03
CY1106175T1 (el) 2011-06-08
DK1200132T4 (da) 2010-04-19
DK200200167A (da) 2002-04-02
DK1200132T3 (da) 2006-10-23

Similar Documents

Publication Publication Date Title
DK0804584T3 (da) Sekvenser af hepatitis C virus genotype 7 og deres anvendelse som profylaktiske, terapeutiske og diagnostiske midler
ATE318309T1 (de) Hcv-spezifische peptide, mittel dazu und ihre verwendung
GR3017770T3 (en) Feline infectious peritonitis virus diagnostic tools.
DE69030124D1 (de) Synthetische Antigene zum Nachweis von Antikörpern gegen Hepatitis C-Virus
ES2144399T3 (es) Clonado del adn de virus de anemia de los pollos.
DE60029327D1 (de) Nukleinsaüre- und aminosaürensequenzen von infectious salmon anaemia virus, und deren verwendung als impfstoffe
ATE349533T1 (de) Zusammensetzung zur diagnose und behandlung von herpes simplex virusinfektionen
DE60138703D1 (de) Transportpeptide abgeleitet von erns protein
NO20005608D0 (no) Strukturelle proteiner fra fisk-pankreatisk-sykdomsvirus og anvendelser derav
ATE346087T1 (de) Hepatitis e-virus aus dem schwein und dessen verwendungen
ATE109158T1 (de) Rubella-e1 und c peptide.
NO20005217D0 (no) DNA som koder for strukturelt protein-1 i infeksiøs lakseanemivirus og anvendelse derav
DK1077999T3 (da) Moraxella catarrhalis-proteiner
ATE359293T1 (de) Von vca-p18 kapsidantigen des epstein-barr-virus abgeleitete peptide und ihre verwendung
EP1191096A4 (de) Neues protein und dessen dns
DK0524421T3 (da) Humant herpesvirus type 6 protein p 100, de tilsvarende DNA-sekvenser, deres fremstilling og anvendelse
ATE328897T1 (de) Verwendung von hev-polypeptiden
DE60129228D1 (de) Humane 7-transmembranproteine und dafür codierende polynukleotide
ZA982996B (en) Synthetic peptides which can be used in biological tests for the detection of infections due to group O HIV-1 viruses.
TW369600B (en) Antigenic peptides for grouping hepatitis C virus, kit comprising the same and methods for its grouping the same

Legal Events

Date Code Title Description
8363 Opposition against the patent
8328 Change in the person/name/address of the agent

Representative=s name: MAIWALD PATENTANWALTSGESELLSCHAFT MBH, 80335 MUENC

8366 Restricted maintained after opposition proceedings
8332 No legal effect for de